| |
| |
|
| Insider
Information: |
Moxie Dwight |
| Relationship: |
CLO & GC |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
137,815 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$468,571 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
137,815 |
|
|
| Total
Value |
$468,571 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Revance Therapeutics, Inc. |
RVNC |
CLO & GC |
2024-03-18 |
137,815 |
2020-02-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
CLO & GC |
• – – |
2024-03-18 |
4 |
S |
$5.04 |
$40,971 |
D/D |
(8,125) |
137,815 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
CLO & GC |
• – – |
2024-03-15 |
4 |
D |
$5.31 |
$17,342 |
D/D |
(3,269) |
145,940 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CLO & GC |
• – – |
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,143 |
149,209 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
134,066 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2023-09-06 |
4 |
AS |
$17.06 |
$187,704 |
D/D |
(11,000) |
44,066 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2023-09-05 |
4 |
AS |
$17.81 |
$424,920 |
D/D |
(23,853) |
55,066 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2023-08-11 |
4 |
D |
$18.91 |
$181,385 |
D/D |
(9,592) |
78,919 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
19,346 |
88,511 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2023-05-15 |
4 |
S |
$34.55 |
$739,338 |
D/D |
(21,401) |
69,165 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2023-03-15 |
4 |
D |
$30.65 |
$224,665 |
D/D |
(7,330) |
48,217 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2023-03-09 |
4 |
S |
$31.59 |
$584,220 |
D/D |
(18,496) |
55,547 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2022-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
42,349 |
74,043 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2022-09-14 |
4 |
AS |
$27.07 |
$297,798 |
D/D |
(11,000) |
31,694 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2022-03-15 |
4 |
D |
$15.79 |
$80,687 |
D/D |
(5,110) |
42,694 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
42,349 |
90,566 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2021-09-27 |
4 |
AS |
$30.00 |
$50,250 |
D/D |
(1,675) |
47,804 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2021-03-15 |
4 |
D |
$27.73 |
$79,890 |
D/D |
(2,881) |
49,479 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2021-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
19,346 |
52,360 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2020-09-30 |
4 |
D |
$25.14 |
$106,493 |
D/D |
(4,236) |
33,014 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
37,250 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
